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humans, and can cause a multitude of infections ranging from
superﬁcial skin infections to invasive diseases. Colonisation is aClin Microbiol Infect 2015; 21: 345.e1–345.e8
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which is frequently found in the anterior nares [1,2].
Transmission of S. aureus and its variant methicillin-resistant
S. aureus (MRSA) between animals and humans frequently has
been reported in industrialised countries, particularly in regions
with high densities of livestock. Not only the livestock-
associated MRSA (LA-MRSA, CC398) but also community-
associated MRSA (CA-MRSA, CC97) can be transmitted from
mammals (i.e. pigs, cattle) and poultry to humans, where it is as
pathogenic as other S. aureus lineages [3,4].
Recently, a highly divergent S. aureus clade was described in
bats, monkeys, and great apes in sub-Sahara Africa, and is now
considered to be a new species termed Staphylococcus schweit-
zeri [5–7]. S. schweitzeri has similar biochemical properties as
S. aureus (i.e. catalase and coagulase positive), can be genotyped
by spa typing and multilocus sequence typing, but differs from
S. aureus at the whole-genome level and the peptidoglycan type
[5,7]. An isolate of a divergent S. aureus clade that has been
retrospectively conﬁrmed as S. schweitzeri was found once in a
human carrier in Gabon [8]. Close contacts of humans with
animals might facilitate the cross-species transmission of
S. aureus and S. schweitzeri, for instance, when preparing and
consuming meat (e.g. monkeys). The extraction and con-
sumption of wildlife (“bushmeat”) is common in sub-Saharan
Africa, particularly in remote regions [9]. However, the trans-
mission of S. aureus and S. schweitzeri between animals and
humans in remote African regions is unclear. The objective of
this study was to investigate the population structure and
transmission of S. aureus and S. schweitzeri between humans and
animals in three remote regions in Côte d’Ivoire, Gabon, and
Democratic Republic of Congo (DR Congo).Materials and methodsEthical clearance
Ethical clearance was obtained from the Comité d’Éthique
Institutionnel, Centre de Recherches Médicales de Lambaréné,
Gabon (CEI-MRU 001/2011), the Comité National d’Éthique et
de la Recherche (CNER), Ministère de la Santé et de l’Hygiène
Publique, République de Côte d’Ivoire (101 10/MSHP/CENR/P),
and the Comité d’Éthique, Ministère de l’Enseignement Supér-
ieur et Universitaire, République Démocratique du Congo
(ESO/CE/018/11).
Written informed consent was signed or ﬁngerprinted by
each participant before enrolment. If the participant was illit-
erate or did not speak French, a local interpreter explained the
study procedures. An independent witness additionally signed
the consent form in these cases.Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectStudy design
A population-based cross-sectional study was performed in
Côte d’Ivoire, Gabon, and DR Congo to take nasal and
pharyngeal swabs from humans and animals. The studied pop-
ulations are characterised by a limited access to ofﬁcial docu-
mentation and health care and, with the exception of the
Ivorian population, rare contact with urban civilisation. Sub-
sistence farming and hunting are essential parts of their lifestyle.
In Côte d’Ivoire, participants were recruited and animals
were sampled in eight villages (Daobly, Gahably, Gouliako,
Keibly, Pauleoula, Ponan, Tai, Zaipobly) in close proximity to
Taï National Park from 4/2012-10/2012 (Fig. 1).
In DR Congo, samples were taken from humans and animals
in seven villages (Bekombo, Bungosani, Ipopé, Iyoko, Lompolé,
Lui Kotale, Nganda) at the border of Salonga-Sud National Park
from 07/2011 to 9/2011 (Fig. 1). In Côte d’Ivoire and DR
Congo, domestic animals were alive and lived in the same
villages as the human participants. Wildlife was dead and hunted
for consumption as “bushmeat” on the same day when samples
were taken.
In Gabon, Babongo pygmies were recruited in six villages
(Village tranquille, Tsibanga, Ossimba, Ndougou, Soga, Egouba)
in Waka National Park in 10/2011. Samples from animals were
collected from 2010 to 2013 in the provinces Moyen Ogooué
and Ngounié, where Waka National Park is located (Fig. 1).
All participants were included if they consented to enrol-
ment. No exclusion criteria were applied. Demographic data
and data on contact with animals (e.g. history of animal bites)
were recorded in standardised questionnaires.
Bacterial isolates
Swabs were taken by gently rubbing a sterile cotton tip in
circular moves against the nasal septum of the anterior nares
and the pharyngeal mucosa. In Gabon, samples were stored in
Amies transport medium (Transwabs, Medical Wire, Corsham,
UK) until culture within a maximum of 2 days in the microbi-
ology laboratory at the Albert Schweitzer Hospital, Lambaréné.
Swabs from DR Congo and Côte d’Ivoire were stored in STTG
medium in liquid nitrogen and shipped to Germany for culture.
All samples were cultured on Columbia blood agar plates,
Columbia CAP selective agar plates (Oxoid, Wesel, Germany),
and SAID agar plates (bioMérieux, Marcy l’Etoile, France) for 18
to 36 hours at 36°C ± 1°C.
Presumptive colonies were screened for a positive catalase
and agglutination test (Pastorex Staph-Plus, Bio-Rad, Marnes-la-
Coquette, France). Species identiﬁcation and susceptibility test
(EUCAST breakpoints) were done using Vitek 2 automated
systems (bioMérieux). Species of S. aureus was conﬁrmed by
the detection of the nuc gene [10]. Identiﬁcation of S. schweitzeriious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 345.e1–345.e8
FIG. 1. Map of the study sites. The national parks in Côte d’Ivoire (Taï National Park), Gabon (Waka National Park), and Democratic Republic of
Congo (Salonga Sud National Park) are shaded in black.
CMI Schaumburg et al. S. aureus complex in remote African regions 345.e3was based on the lack of nuc detection, its phylogenetic
divergent position using multilocus sequence typing, and a
similar biochemical proﬁle as S. aureus as assessed with GP ID
Card (bioMérieux) [7].
Carriers were deﬁned as a human or animal being colonised
in the nose and/or throat. If an individual was colonised with an
identical isolate at different body sites (based on spa typing),
one isolate was included in the ﬁnal analysis in order to report
nonduplicate isolates only.
Molecular characterisation
Genes encoding selected virulence factors were detected by
multiplex polymerase chain reactions (PCRs) [11]. Methicillin
resistance was conﬁrmed by the detection of mecA, and all
MRSA were tested for arginine catabolic mobile element
[12,13]. All isolates were spa typed, and multilocus sequence
typing (MLST) was done exemplarily for one isolate of each spa
type in each country and each group (humans, animals) [14,15].
The concatenated sequences of MLST housekeeping genes
were used to construct a Neighbour Joining Tree (MEGA5,
http://www.megasoftware.net). The divergence between two
groups was assessed using the Maximum Composite Likelihood
model (MEGA5).Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InStatistics
Antimicrobial resistance rates were compared between animals
and humans using Pearson’s χ2 test or Fisher exact test, the
software R (http://cran.r-project.org, version: 2.13.1), and the
package EPICALC.ResultsIn total, 1288 participants and 698 animals were sampled in
Côte d’Ivoire, Gabon, and DR Congo (Fig. 1, Table 1). The
median age of humans ranged from 15 years (Gabon) to 30
years (Côte d’Ivoire). Human S. aureus colonisation rates were
similar in Gabon (34.0%, n = 35) and Côte d’Ivoire (32.4%,
n = 222) but lower in DR Congo (21.4%, n = 107). Although
animal bites were not recorded for participants from DR
Congo, 3.9% (n = 4, Gabon) and 20.7% (n = 142, Côte d’Ivoire)
had a history of animal injuries (Table 1). The majority reported
snake bites (8.2%, n = 65), followed by dog bites (4.6%, n = 36)
and bites by nonhuman primates (0.9%, n = 7).
The distribution of sampled domestic animals (i.e. ruminants,
fowls, dogs, cats) and wildlife (i.e. nonhuman primates, rodents,
ruminants, reptiles) was heterogeneous among all study sites.fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 345.e1–345.e8
TABLE 1. Demographic data of the study populations
Côte d’Ivoire Gabon Democratic Republic of Congo
Humans Total number (n) 686 103 499
Median age in years (range) 30 (0-80) 15 (0.5-70) 22.5 (0-87)
Proportion of female subjects (%) 62.7 45.6 53.1
Carrier rate (%) 32.4 34.0 21.4
History of animal bites (%) 3.9 20.7 ND
Animal Total number (n) 556 128 14
Domestic animals (%) 90.1 21.4 9.4
Wildlife (%) 9.9 78.6 90.6
ND, not done.
345.e4 Clinical Microbiology and Infection, Volume 21 Number 4, April 2015 CMIThe proportion of domestic animals among all animals was
highest in Côte d’Ivoire (90.3%, n = 501), whereas wildlife was
predominant in Gabon (90.8%, n = 116) and DR Congo (88%,
n = 11, Table 1). S. aureus colonisation rates were highest in
ruminants (19.6%, n = 54), followed by nonhuman primates
(19.0%, n = 15), cats (7.1%, n = 3), and dogs (3.0%, n = 3).
S. schweitzeri was only found in nonhuman primates, which
were colonised in 26.6% (n = 21).
Nine human carriers had a culture-conﬁrmed S. aureus skin
infection. The same strain (based on spa typing) as the skin lesion
also was found in the nose and/or throat of six participants.
Three participants with a skin infection were not colonised.
The staphylococcal isolates were separated into two phylo-
genetic groups. Group 1 included 495 S. aureus isolates pre-
dominated by ST152 (17.4%, n = 86), ST15 (16.8%, n = 83), and
ST5 (10.9%, n =54). Animal species that carried isolates belonging
to group 1 were dogs (Canis sp.), goats (Capra sp.), guenons
(Cercopithecus sp.), mangabeys (Lophocebus sp.), talapoins (Mio-
pithecus sp.), and sheep (Ovis sp., Supplementary Table S1). The
habitat regions of these species are terrestrial or semiterrestrial.
The divergent group 2 consisted of 24 S. schweitzeri isolates,
and ST2295 (16.7%, n = 4), ST1872, ST1874, and ST2474 (each
8.3%, n = 2) were predominant. All S. schweitzeri isolates were
isolated from nonhuman primates and were nuc PCR negative.
The mean distance between group 1 and 2 was 0.083 base
substitutions per site. Within group 1, we detected a cluster of
monkey-associated STs (ST1838, ST1851, ST1854, ST1925,
ST2721). Of these, only isolates belonging to ST1854 were nuc
negative. Of note, two ST395 isolates from human carriers also
were nuc negative. Isolates from wildlife and domestic animals
were distinctly scattered in group 1, which is dominated by
isolates from humans. In contrast, no isolates from humans
were found in group 2 (Fig. 2).
S. aureus belonging to ST1, ST5, ST6, ST8, ST15, ST101,
ST121, ST152, ST188, ST567, and ST1472 were found in
humans, domestic animals, and/or wildlife. A possible trans-
mission of these isolates between humans and animals was
assessed by spa typing, which has a higher discriminatory power
than MLST (Table 2). Transmission of S. aureus occurred more
frequently between humans and domestic animals thanClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectbetween humans and wildlife. S. schweitzeri isolates were not
found among humans or domestic animals (Table 2).
One early branching isolate (ST2353, nuc negative) from a 14-
year-old female carrier in DR Congo did not cluster with any
group (Fig. 2). The delineation of ST2353 from group 1, the
closest related clade, was supported by a bootstrap value of 100%
(Supplementary Fig. S1). The average distances of ST2353 from
ST152 and ST2022 (taken as reference STs from group 1 and 2,
respectively) were 0.035 and 0.054 base substitution per site,
respectively. ST2353 had an isolated position regarding theMLST
allelic proﬁle; the closest relatives were ST1857, ST2022, and
ST2295, which were quadruple locus variants of ST2353. ST2353
was more similar to typical S. aureus STs than to S. schweitzeri,
S. simiae, or the early branching ST1223 and ST1850 (Fig. S1).
Antimicrobial resistance was only detected in S. aureus and
not in S. schweitzeri (Table 3). Overall, the antimicrobial resis-
tance rates were higher in S. aureus from humans compared
with animals for penicillin (57.3 vs. 81.7%, p < 0.005), cefoxitin
(1.1 vs. 4.7%, p 0.2) and cotrimoxazol (23.6 vs. 31.4%, p 0.15).
Compared with the pygmy population in Gabon, S. aureus
from Côte d’Ivoire and DR Congo showed higher resistance
rates to penicillin, cotrimoxazol, and tetracyclin (Table 3). The
MRSA rate was 5.3% (Côte d’Ivoire) and 1.7% (DR Congo). No
MRSA was detected in the Gabonese population. In Côte
d’Ivoire, 94.1% (n = 16) of all MRSA belonged to ST88 (t186,
t786, Panton-Valentine leukocidin (PVL) negative). One MRSA
isolate was isolated from a sheep (ST2947, t186, PVL negative,
Table 3). In DR Congo, the two MRSA were isolated from
humans and belonged to ST8 (t1476, PVL negative, arginine
catabolic mobile element (ACME) negative).
In methicillin-susceptible S. aureus, PVL was the most prev-
alent virulence factor (25% to 40.4%, Table 3). Only the
enterotoxin encoding genes (seb, sec) and toxic shock syn-
drome toxin (tst) were found in S. schweitzeri isolates (Table 3).DiscussionOur study assessed a possible transmission of S. aureus
and S. schweitzeri among humans, domestic animals, and wildlifeious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 345.e1–345.e8
FIG. 2. Phylogenetic tree of Staphylococcus aureus and Staphylococcus schweitzeri in Côte d’Ivoire, Gabon, and DR Congo. Concatenated sequences of
the seven multilocus sequence typing housekeeping genes were used to construct a neighbour-joining tree. The countries of origin are marked by
colours (yellow: Côte d’Ivoire, blue: DR Congo, green: Gabon). Black lines indicate isolates from nonhuman primates.
CMI Schaumburg et al. S. aureus complex in remote African regions 345.e5in three remote African regions. We found evidence that
transmission of S. aureus between humans and domestic animals
could occur. S. schweitzeri was frequently found in nonhuman
primates but was not detected in humans despite frequent
exposure to bushmeat.
In human participants, 3.9% to 20.7% reported animal bites
in the past, which is in line with a report from Uganda, where
19.3% reported injuries or close contact with primates [16].
Not only injuries by wild animals but also bushmeat hunting and
consumption are risk factors for the transmission of pathogens
between animals and humans [9]. Bushmeat trade andClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Inconsumption is highest in West and Central Africa. Approxi-
mately 300 g bushmeat are consumed per person per day in the
Congo Basin, resulting in 4.5 million tons of extracted bushmeat
per year [9]. Therefore, our remote studied populations can be
considered as populations with a high risk of becoming exposed
to zoonotic pathogens from wildlife.
We and others recently reported a highly divergent S. aureus
clade in African nonhuman primates and bats that is now
considered to be a new species, S. schweitzeri [5,6]. S. schweitzeri
harbours a nuc homologue with similar thermostable nuclease
activity as S. aureus [17]. Despite frequent exposures tofectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 345.e1–345.e8
TABLE 2. Transmission of Staphylococcus aureus between humans, domestic animals, and wildlife
MLST sequence type
Human Domestic animal Wildlife
Countryspa type (n of isolates) spa type (n of isolates) Species spa type (n of isolates) Species
ST5 t002 (20) — — t002 (1) Civet Democratic
Republic of Congo
t311 (6) t311 (1) Goat — — Côte d’Ivoire
ST6 — t1476 (5) Cat, dog, goat t1476 (1) Monkey Côte d’Ivoire
ST8 t008 (2) t008 (1) Goat — — Côte d’Ivoire
ST15 t084 (32) t084 (12) Goat, sheep t084 (1) Monkey Côte d’Ivoire
t346 (8) t346 (2) Goat — — Côte d’Ivoire
ST88/ST2947* t186 (9)* t186 (1)* Sheep — — Côte d’Ivoire
ST121 t314 (6) t314 (2) Sheep — — Côte d’Ivoire
ST152 t355 (55) t355 (16) Chicken, dog, goat, sheep — — Côte d’Ivoire
t4235 (1) t4235 (2) Goat, sheep — — Côte d’Ivoire
ST567 t13523 (1) t13523 (1) Sheep — — Côte d’Ivoire
ST1472 t318 (2) t318 (1) Goat — — Côte d’Ivoire
MLST, multilocus sequence typing.
*MRSA isolates.
345.e6 Clinical Microbiology and Infection, Volume 21 Number 4, April 2015 CMInonhuman primates, we did not ﬁnd S. schweitzeri in humans. In
contrast, some isolates from monkeys clustered with typical
human-associated isolates (i.e. ST1, ST6, ST15, Fig. 2). This ﬁnding
suggests that a transmission from humans to animals is more
likely than vice versa. This transmission could be facilitated by
overlapping habitats of humans (terrestrial), domestic animals
(terrestrial), and wildlife (terrestrial and semiterrestrial,
Supplementary Table S1). It is also possible that animal-associated
lineages were transmitted to humans, where they clonally
expanded. However, the polyclonal population structure in
humans argues against this scenario. As the monkeys have been
hunted and handled by humans, we cannot rule out that these
animals were contaminated with S. aureus after death and did not
carry human-associated S. aureus lineages during lifetime. We
rank this possibility as low, as swabs were taken from anteriorTABLE 3. Antimicrobial resistance and virulence factors of Staphyl
Côte d’Ivoire Gabon
S. aureus
(n [ 323)
S. schweitzeri
(n [ 1)
S. aureus
(n [ 52)
Antimicrobial resistance Penicillin 289 (89.5) 0 (0) 13 (25)
Cefoxitin 17 (5.3) 0 (0) 0 (0)
Cotrimoxazole 110 (34.1) 0 (0) 1 (1.9)
Tetracycline 229 (70.9) 0 (0) 3 (5.8)
Erythromycin 8 (2.5) 0 (0) 0 (0)
Clindamycin 0 (0) 0 (0) 5 (9.6)
Rifampicin 55 (17.0) 0 (0) 0 (0)
Virulence factors PVL 129 (39.9) 0 (0) 21 (40.4)
SEA 67 (20.7) 0 (0) 2 (3.9)
SEB 25 (7.7) 0 (0) 9 (17.3)
SEC 33 (10.2) 0 (0) 6 (11.5)
ETA 9 (2.8) 0 (0) 0 (0)
ETB 2 (0.6) 0 (0) 32 (61.5)
TSST 35 (10.8) 0 (0) 0 (0)
Three most frequent
MLST sequence types (n)
1 ST152 (84) ST2946 (1) ST30 (9)
2 ST15 (6) NA ST1 (8)
3 ST8 (26) NA ST1854 (4
Figures are n (%) unless indicated otherwise.
Isolates that were not typable by MLST were allocated to S. aureus if they were nuc polymer
were grouped with S. schweitzeri.
MLST, multilocus sequence typing; NA, not applicable; NT, not typable.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectnares and throat, which are usually not touched by humans during
handling of bushmeat. However, easily accessible body sites of
monkeys might remain subject to contamination by humans.
A transmission of S. aureus from humans to great apes has
been reported from African sanctuaries and research centres in
Uganda, Zambia, and Gabon [18,19]. Although direct skin con-
tact of humans and animals might be the transmission route in
captive animals, other pathsmight apply for a transmission towild
nonhuman primates. Contacts of wild animals with human faeces
or secretions, either directly or through soil or water, could
facilitate a transmission. One study from Uganda conﬁrmed a
transmission of Escherichia coli between humans, livestock, and
gorillas [20]. In contrast, a study from Gabon did not show any
evidence for such a transmission of E. coli from human faeces to
wildlife through soil and surface waters [21].ococcus aureus isolates
Democratic Republic of
Congo Total
S. schweitzeri
(n [ 17)
S. aureus
(n [ 120)
S. schweitzeri
(n [ 6)
S. aureus
(n [ 495)
S. schweitzeri
(n [ 24)
0 (0) 81 (67.5) 0 (0) 383 (77.4) 0 (0)
0 (0) 2 (1.7) 0 (0) 20 (4.0) 0 (0)
0 (0) 37 (30.8) 0 (0) 148 (29.9) 0 (0)
0 (0) 30 (25) 0 (0) 262 (52.9) 0 (0)
0 (0) 2 (1.7) 0 (0) 10 (2.0) 0 (0)
0 (0) 2 (1.7) 0 (0) 5 (1.4) 0 (0)
0 (0) 0 (0) 0 (0) 55 (11.1) 0 (0)
0 (0) 30 (25) 0 (0) 180 (36.4) 0 (0)
0 (0) 30 (25) 0 (0) 99 (20.0) 0 (0)
3 (17.6) 16 (13.3) 0 (0) 50 (10.1) 3 (12.5)
2 (11.8) 12 (10) 1 (16.7) 51 (10.3) 3 (12.5)
0 (0) 6 (5) 0 (0) 15 (3.0) 0 (0)
0 (0) 3 (2.5) 0 (0) 37 (7.5) 0 (0)
1 (5.9) 2 (1.7) 1 (16.7) 37 (7.5) 2 (8.3)
ST2295 (4) ST5 (51) ST2474 (2) — —
NT (2) ST8 (16) ST2475 (1) — —
) ST1872 (2) ST15 (13) ST2476 (1) — —
ase chain reaction positive [10]. Isolates being nuc polymerase chain reaction negative
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 345.e1–345.e8
CMI Schaumburg et al. S. aureus complex in remote African regions 345.e7In a human carrier from DR Congo, we found an early
branching ST2353 that was unrelated to other early branching
S. aureus isolates (ST1223, ST1850) [22,23]. To the best of
our knowledge, similar STs have not been reported yet. The
closest related STs are quadruple locus variants of ST2353
and cluster in group 2 (Fig. 2). To resolve the phylogenetic
position of this ST, comparative whole-genome analyses are
warranted.
The resistance rates to antimicrobial agents differed mark-
edly between isolates from the three studied populations and
between S. aureus and S. schweitzeri. There seemed to be a
trend from low (Gabon), medium (DR Congo), and high (Côte
d’Ivoire) levels of antimicrobial resistance in S. aureus that might
mirror the contact with healthcare institutions and access to
antibiotics. The high resistance rates to penicillin (89.5%) and
cefoxitin (5.3%) in S. aureus from Côte d’Ivoire correspond to
resistance rates in urban populations in Gabon (penicillin
resistance: 95%, methicillin resistance: 3%), Nigeria (methicillin
resistance: 8%), or Kenya (penicillin resistance: 69.8%, methi-
cillin resistance: 7%) [8,24,25]. Almost all MRSA isolates from
Côte d’Ivoire belonged to ST88 (94.1%). The ST88-MRSA-III/IV
is widely distributed in sub-Saharan Africa and is termed the
African MRSA clone [26]. We isolated an ST88-MRSA from a
sheep in Côte d’Ivoire; others found this lineage in pigs from
Senegal [27].
Although our study is valuable to understand the trans-
mission of S. aureus and S. schweitzeri between animals and
humans, some limitations need to be addressed. First, we were
unable to include data on animal exposure and bites of the
studied population in DR Congo. We assume that this popu-
lation has similar exposures and contacts to wildlife as the
Gabonese pygmies due to similar living conditions. Second, the
cross-sectional study design limits conclusions regarding the
direction of transmission. Future longitudinal studies are
therefore warranted. Third, because one spa type can belong to
different MLST sequence types, we might have underestimated
the diversity of STs. Fourth, apart from the anterior nares and
throat, we did not sample other typical S. aureus colonisation
sites (e.g. hands, axilla, and groin) and might have missed
additional S. aureus carriers.
In conclusion, we provide evidence for a transmission of
human-associated S. aureus to domestic animals and to some
extent also to wildlife in rural Africa. No transmission of the
monkey-associated S. schweitzeri to humans was detected,
although the studied populations have frequent contact with
wildlife through bushmeat hunting and consumption. How-
ever, S. schweitzeri might have a zoonotic potential due to
the close phylogenetic relation of humans and nonhuman
primates.Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InTransparency declarationThe study was funded by the Deutsche Forschungsgemeinschaft
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